Cargando…

Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

Detalles Bibliográficos
Autores principales: Schultz, Neil M, Shore, Neal D, Chowdhury, Simon, Klotz, Laurence H, Concepcion, Raoul S, Penson, David F, Karsh, Lawrence I, Yang, Hongbo, Brown, Bruce A, Barlev, Arie, Flanders, Scott C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166278/
https://www.ncbi.nlm.nih.gov/pubmed/30285696
http://dx.doi.org/10.1186/s12894-018-0397-5
_version_ 1783360007459307520
author Schultz, Neil M
Shore, Neal D
Chowdhury, Simon
Klotz, Laurence H
Concepcion, Raoul S
Penson, David F
Karsh, Lawrence I
Yang, Hongbo
Brown, Bruce A
Barlev, Arie
Flanders, Scott C
author_facet Schultz, Neil M
Shore, Neal D
Chowdhury, Simon
Klotz, Laurence H
Concepcion, Raoul S
Penson, David F
Karsh, Lawrence I
Yang, Hongbo
Brown, Bruce A
Barlev, Arie
Flanders, Scott C
author_sort Schultz, Neil M
collection PubMed
description
format Online
Article
Text
id pubmed-6166278
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61662782018-10-10 Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials Schultz, Neil M Shore, Neal D Chowdhury, Simon Klotz, Laurence H Concepcion, Raoul S Penson, David F Karsh, Lawrence I Yang, Hongbo Brown, Bruce A Barlev, Arie Flanders, Scott C BMC Urol Correction BioMed Central 2018-10-01 /pmc/articles/PMC6166278/ /pubmed/30285696 http://dx.doi.org/10.1186/s12894-018-0397-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Schultz, Neil M
Shore, Neal D
Chowdhury, Simon
Klotz, Laurence H
Concepcion, Raoul S
Penson, David F
Karsh, Lawrence I
Yang, Hongbo
Brown, Bruce A
Barlev, Arie
Flanders, Scott C
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
title Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
title_full Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
title_fullStr Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
title_full_unstemmed Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
title_short Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials
title_sort correction to: number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the strive and terrain trials
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166278/
https://www.ncbi.nlm.nih.gov/pubmed/30285696
http://dx.doi.org/10.1186/s12894-018-0397-5
work_keys_str_mv AT schultzneilm correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT shoreneald correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT chowdhurysimon correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT klotzlaurenceh correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT concepcionraouls correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT pensondavidf correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT karshlawrencei correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT yanghongbo correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT brownbrucea correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT barlevarie correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials
AT flandersscottc correctiontonumberneededtotreatanalysisofclinicalprogressioninpatientswithmetastaticcastrationresistantprostatecancerinthestriveandterraintrials